Evidence map›Paper›PMID 16872288›Full record

ArticleJournal of medical primatology2006

Dynamic evolution of antibody populations in a rhesus macaque infected with attenuated simian immunodeficiency virus identified by surface plasmon resonance.

J D Steckbeck, H J Grieser, T Sturgeon, R Taber, A Chow, J Bruno, M Murphy-Corb, R C Montelaro, K S Cole

Open access · greenAbstract read
In one paragraph

Article in Journal of medical primatology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

J D SteckbeckDepartment of Medicine, Infectious Diseases Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
H J Grieser
T Sturgeon
R Taber
A Chow
J Bruno
M Murphy-Corb
R C Montelaro
K S Cole
University of Pittsburgh · USArqule (United States) · US

Funding

DEVELOPMENT OF AN OPTIMAL LIVE ATTENUATED SIV VACCINEP01AI028243 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MONTELARO, RONALD C · 1998 to 2002
$4.4M
Mechanisms of SIV NeutralizationR01AI052058 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COLE, KELLY STEFANO · 2002 to 2005
$1.2M
NIAID NIH HHS 2P01 AI 28243NIAID NIH HHS P01 AI028243NIAID NIH HHS R01 AI052058NIAID NIH HHS R01 AI 52058
6 · The paper itself

Abstract

backgroundIncreasing evidence suggests that an effective AIDS vaccine will need to elicit broadly neutralizing antibody responses. However, the mechanisms of antibody-mediated neutralization have not been defined. Previous studies from our lab have identified significant differences in the rates of antibody binding to trimeric SIV envelope proteins that correlate with neutralization sensitivity. Importantly, these results demonstrate differences in monoclonal antibody (MAb) binding to neutralization-sensitive and neutralization-resistant envelope proteins, suggesting that one mechanism for virus neutralization may be related to the stability of antibody binding. To date, little has been done to evaluate the binding properties of polyclonal serum antibodies elicited by SIV infection or vaccination.

methodsIn the current study, we translate these findings with MAbs to study antibody binding properties of polyclonal serum antibody responses generated in rhesus macaques infected with attenuated SIV. Quantitative and qualitative binding properties of well-characterized longitudinal serum samples to trimeric, recombinant SIV gp140 envelope proteins were analyzed using surface plasmon resonance (SPR) technology (Biacore).

resultsResults from these studies identified two antibody populations in most of the samples analyzed; one antibody population exhibited fast association/dissociation rates (unstable) while the other population demonstrated slower association/dissociation rates (stable). Over time, the percentage of the total binding response of each antibody population evolved, demonstrating a dynamic evolution of the antibody response that was consistent with the maturation of antibody responses defined using our standard panel of serological assays. However, the current studies provided a higher resolution analysis of polyclonal antibody binding properties, particularly with respect to the early time-points post-infection (PI), that is not possible with standard serological assays. More importantly, the increased stability of the antibody population with time PI corresponded with potent neutralization of homologous SIV in vitro.

conclusionsThese results suggest that the stability of the antibody-envelope interaction may be an important mechanism of serum antibody virus neutralization. In addition, measurements of the 'apparent' rates of association and dissociation may offer unique numerical descriptors to characterize the level of antibody maturation achieved by candidate vaccine strategies capable of eliciting broadly neutralizing antibody responses.

Indexed as

Amino Acid SequenceAnimalsAntibodies, ViralAntibody AffinityBlotting, WesternDisease Models, AnimalEnzyme-Linked Immunosorbent AssayMacaca mulattaMolecular Sequence DataRecombinant ProteinsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusSurface Plasmon ResonanceViral Envelope ProteinsViral LoadAntibodies, ViralRecombinant ProteinsViral Envelope Proteins

Identifiers

PMID16872288
PMCPMC3361734
OpenAlexW2025538726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.